Boundless Bio, Inc. (BOLD) stock
BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.46+0.00 (0.00%)
Close on Nov 12, 2026Market cap $55.96MP/E –Yield –
Boundless Bio total assets
Total assets on the balance sheet at the end of each period.
Boundless Bio's total assets was $63.59M at Sep 30, 2026. For fiscal 2025 it was $157.06M, down 23.9% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $157.06M | -23.9% |
| FY2024 | Dec 31, 2024 | $206.41M | +58.9% |
| FY2023 | Dec 31, 2023 | $129.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $63.59M | -62.3% |
| Q2 FY2026 | Jun 30, 2026 | $73.74M | -58.9% |
| Q1 FY2026 | Mar 31, 2026 | $140.97M | -26.3% |
| Q4 FY2025 | Dec 31, 2025 | $157.06M | -23.9% |
| Q3 FY2025 | Sep 30, 2025 | $168.72M | -3.6% |
| Q2 FY2025 | Jun 30, 2025 | $179.45M | -4.6% |
| Q1 FY2025 | Mar 31, 2025 | $191.24M | +63.3% |
| Q4 FY2024 | Dec 31, 2024 | $206.41M | +58.9% |
| Q3 FY2024 | Sep 30, 2024 | $175.09M | – |
| Q2 FY2024 | Jun 30, 2024 | $188.20M | – |
| Q1 FY2024 | Mar 31, 2024 | $117.08M | – |
| Q4 FY2023 | Dec 31, 2023 | $129.89M | – |
See a number that looks wrong?